Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
The price of Carters Inc (NYSE: CRI) closed at $29.03 in the last session, up 2.87% from day before closing price of $28.22. In other words, the price has increased by $2.87 from its previous closing price. On the day, 1.32 million shares were traded. CRI stock price reached its highest trading level at $29.18 during the session, while it also had its lowest trading level at $28.18.
Ratios:
We take a closer look at CRI’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 3.13 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 7.54. For the most recent quarter (mrq), Quick Ratio is recorded 1.03 and its Current Ratio is at 2.20. In the meantime, Its Debt-to-Equity ratio is 1.32 whereas as Long-Term Debt/Eq ratio is at 1.17.
On April 28, 2025, Barclays started tracking the stock assigning a Underweight rating and target price of $25.
Citigroup Upgraded its Sell to Neutral on November 12, 2024, while the target price for the stock was maintained at $50.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Aug 07 ’25 when Jenkins Jeff bought 10,853 shares for $25.52 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CRI now has a Market Capitalization of 1063819584 and an Enterprise Value of 1843780096. As of this moment, Carters’s Price-to-Earnings (P/E) ratio for their current fiscal year is 7.71, and their Forward P/E ratio for the next fiscal year is 12.65. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.37 while its Price-to-Book (P/B) ratio in mrq is 1.24. Its current Enterprise Value per Revenue stands at 0.651 whereas that against EBITDA is 6.663.
Stock Price History:
The Beta on a monthly basis for CRI is 1.07, which has changed by -0.5661799 over the last 52 weeks, in comparison to a change of 0.17342639 over the same period for the S&P500. Over the past 52 weeks, CRI has reached a high of $68.69, while it has fallen to a 52-week low of $23.38. The 50-Day Moving Average of the stock is 4.50%, while the 200-Day Moving Average is calculated to be -23.29%.
Shares Statistics:
According to the various share statistics, CRI traded on average about 1.49M shares per day over the past 3-months and 1385620 shares per day over the past 10 days. A total of 36.47M shares are outstanding, with a floating share count of 36.08M. Insiders hold about 0.97% of the company’s shares, while institutions hold 124.84% stake in the company. Shares short for CRI as of 1757894400 were 3949738 with a Short Ratio of 2.65, compared to 1755216000 on 4766650. Therefore, it implies a Short% of Shares Outstanding of 3949738 and a Short% of Float of 14.21.
Dividends & Splits
The forward annual dividend rate for CRI is 2.10, which was 2.65 in the trailing 12 months. Against a Trailing Annual Dividend Yield of 0.09390504. The stock’s 5-year Average Dividend Yield is 1.66. The current Payout Ratio is 62.52% for CRI, which recently paid a dividend on 2025-08-26 with an ex-dividend date of 2025-08-26. Stock splits for the company last occurred on 2006-06-07 when the company split stock in a 2:1 ratio.
Earnings Estimates
The firm’s stock currently is rated by 5.0 analysts. The consensus estimate for the next quarter is $1.53, with high estimates of $1.64 and low estimates of $1.39.
Analysts are recommending an EPS of between $3.47 and $2.86 for the fiscal current year, implying an average EPS of $3.11. EPS for the following year is $2.29, with 6.0 analysts recommending between $3.01 and $1.8.
Revenue Estimates
According to 4 analysts,. The current quarter’s revenue is expected to be $760.11M. It ranges from a high estimate of $779M to a low estimate of $727.36M. As of. The current estimate, Carters Inc’s year-ago sales were $758.46MFor the next quarter, 4 analysts are estimating revenue of $860.57M. There is a high estimate of $902M for the next quarter, whereas the lowest estimate is $792.93M.
A total of 4 analysts have provided revenue estimates for CRI’s current fiscal year. The highest revenue estimate was $2.9B, while the lowest revenue estimate was $2.74B, resulting in an average revenue estimate of $2.84B. In the same quarter a year ago, actual revenue was $2.84BBased on 4 analysts’ estimates, the company’s revenue will be $2.81B in the next fiscal year. The high estimate is $2.85B and the low estimate is $2.71B.
